 EPA prevention restenosis post PTCA effect fish oil restenosis patients coronary balloon angioplasty addition pharmacotherapy subjects eicosapentanoic acid EPA Treatment twenty-four hours successful percutaneous transluminal coronary angioplasty PTCA months therapy participants coronary arteriography exercise scintigraphy exercise electrocardiography clinical evaluation Follow-up evaluation coronary lesions patients Partial significant restenosis patients vessels presence severe stenosis PTCA dissection thrombus multilesion PTCA bleeding time values restenosis Dilation left anterior descending LAD residual stenosis equal restenosis patients related difficulty fish oil Furthermore results advantage restenosis rates